Oxytocin for frontotemporal dementia: A randomized dose-finding study of safety and tolerability

OBJECTIVE: To determine the safety and tolerability of 3 doses of intranasal oxytocin (Syntocinon; Novartis, Bern, Switzerland) administered to patients with frontotemporal dementia (FTD). METHODS: We conducted a randomized, parallel-group, double-blind, placebo-controlled study using a dose-escalat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Finger, Elizabeth C., MacKinley, Julia, Blair, Mervin, Oliver, Lindsay D., Jesso, Sarah, Tartaglia, Maria C., Borrie, Michael, Wells, Jennie, Dziobek, Isabel, Pasternak, Stephen, Mitchell, Derek G.V., Rankin, Katherine, Kertesz, Andrew, Boxer, Adam
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4336088/
https://ncbi.nlm.nih.gov/pubmed/25503617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001133
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados